(MedPage Today) — One of the largest autism trials of leucovorin (Wellcovorin), a drug used to treat cerebral folate deficiency, was retracted on Jan. 29 by the European Journal of Pediatrics, a Springer Nature journal.
The randomized, double…
Source link
